FierceBiotech 13 abr 2026 Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix
FierceBiotech 13 abr 2026 Allogene’s off-the-shelf CAR-T erases lingering lymphoma cells in early slice of data
FierceBiotech 12 abr 2026 GSK CEO's 'scientific courage' propels plans for medley of phase 3 trials for Hansoh-partnered ADC
FierceBiotech 10 abr 2026 'Can it actually deliver?': Why Big Pharma is making the leap to the quantum realm
FierceBiotech 10 abr 2026 Philips recalls Trilogy Evo ventilator software, warns of ‘under-delivery’ of therapy
FierceBiotech 9 abr 2026 J&J launches latest version of its pulsed ablation device after nabbing CE Mark
FierceBiotech 9 abr 2026 Judge rules that HHS must face states' lawsuit over RFK Jr.'s agency overhaul, massive layoffs
FierceBiotech 9 abr 2026 'It’s going to be huge': The 'diabolical' molecule poised to become biotech's next gold rush
FierceBiotech 9 abr 2026 Gilead pays Kymera $45M to glue preclinical protein degrader onto burgeoning oncology pipeline
FierceBiotech 9 abr 2026 Boehringer hands over funding, marketing rights for Click’s digital therapeutic
FierceBiotech 9 abr 2026 In a first, a CAR-T cell therapy drives 3 autoimmune diseases into remission in a single patient
FierceBiotech 9 abr 2026 Avalyn plans IPO to fund phase 3 trials of inhaled versions of approved respiratory drugs
FierceBiotech 9 abr 2026 Roche takes 'leap of faith' with $20M bet on C4T’s antibody-targeted protein degraders
FierceBiotech 8 abr 2026 Medline hit with FDA warning letter over defective heart syringes, safety hazards
FierceBiotech 8 abr 2026 Artivion nabs PMA clearance for aortic stent graft system, triggers Endospan buyout option